4D Molecular Therapeutics, Inc. short interest in 2023
In 2023, 4D Molecular Therapeutics, Inc.'s disclosed short interest ran from 6.96% of shares outstanding on 13 Jan 2023 to 7.53% on 29 Dec 2023, a change of +0.57 percentage points. The year's high was 10.55% on 30 Jun 2023 and its low 6.52% on 28 Feb 2023, averaging 8.63% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.51 days on 30 Nov 2023. Full history: 4D Molecular Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 6.96% (13 Jan 2023)
- End of year
- 7.53% (29 Dec 2023)
- Change
- +0.57 pp
- High
- 10.55% (30 Jun 2023)
- Low
- 6.52% (28 Feb 2023)
- Average
- 8.63%
- Highest days to cover
- 16.51 (30 Nov 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 6.96% | 7.97 | |
| 31 Jan 2023 | 6.69% | 8.95 | |
| 15 Feb 2023 | 6.89% | 9.42 | |
| 28 Feb 2023 | 6.52% | 4.76 | |
| 15 Mar 2023 | 7.86% | 6.40 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 9.37% | 6.79 | |
| 14 Apr 2023 | 9.52% | 7.57 | |
| 28 Apr 2023 | 8.53% | 3.31 | |
| 15 May 2023 | 8.93% | 4.14 | 10-Q filed, results (8-K) |
| 31 May 2023 | 9.35% | 5.68 | |
| 15 Jun 2023 | 10.29% | 5.26 | |
| 30 Jun 2023 | 10.55% | 4.90 | |
| 14 Jul 2023 | 9.34% | 12.28 | |
| 31 Jul 2023 | 9.28% | 14.66 | |
| 15 Aug 2023 | 8.48% | 12.24 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 8.48% | 15.18 | |
| 15 Sep 2023 | 8.77% | 8.30 | |
| 29 Sep 2023 | 9.34% | 11.75 | |
| 13 Oct 2023 | 9.75% | 15.68 | |
| 31 Oct 2023 | 8.35% | 8.78 | |
| 15 Nov 2023 | 8.81% | 10.74 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 8.42% | 16.51 | |
| 15 Dec 2023 | 9.20% | 10.05 | |
| 29 Dec 2023 | 7.53% | 6.56 |
See also: 4D Molecular Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.